BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 24876755)

  • 1. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
    Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
    World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.
    Wang DR; Tang D
    World J Gastroenterol; 2008 Jan; 14(4):524-31. PubMed ID: 18203283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].
    Qi J; Zhu YQ; Luo J; Tao WH
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1954-7. PubMed ID: 17923031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
    Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
    World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
    Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
    Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation risks of SFRP2 hypermethylation between precancerous disease and colorectal cancer.
    Sui C; Wang G; Chen Q; Ma J
    Tumour Biol; 2014 Oct; 35(10):10457-65. PubMed ID: 25053594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative detection of SRY-Box 21 (
    Moradi K; Babaei E; Hosseinpour Feizi MA; Safaralizadeh R; Rezvani N
    Indian J Cancer; 2021; 58(2):217-224. PubMed ID: 33402569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.
    Lenhard K; Bommer GT; Asutay S; Schauer R; Brabletz T; Göke B; Lamerz R; Kolligs FT
    Clin Gastroenterol Hepatol; 2005 Feb; 3(2):142-9. PubMed ID: 15704048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps.
    Naini MA; Mokarram P; Kavousipour S; Zare N; Atapour A; Zarin1 MH; Mehrabani G; Borji M
    Asian Pac J Cancer Prev; 2016; 17(4):2185-93. PubMed ID: 27221916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients.
    Chang E; Park DI; Kim YJ; Kim BK; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim HD; Kim DH; Kim YH
    Hepatogastroenterology; 2010; 57(101):720-7. PubMed ID: 21033217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Wif-1 methylation and β-catenin expression in colorectal serrated lesions].
    Fang Y; Wang L; Zhang Y; Ge C; Xu C
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):15-9. PubMed ID: 24713243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas.
    Voorham QJ; Janssen J; Tijssen M; Snellenberg S; Mongera S; van Grieken NC; Grabsch H; Kliment M; Rembacken BJ; Mulder CJ; van Engeland M; Meijer GA; Steenbergen RD; Carvalho B
    BMC Cancer; 2013 Dec; 13():603. PubMed ID: 24350795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer.
    Tang D; Liu J; Wang DR; Yu HF; Li YK; Zhang JQ
    Clin Invest Med; 2011 Apr; 34(2):E88-95. PubMed ID: 21463549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance.
    Abdelmaksoud-Dammak R; Miladi-Abdennadher I; Saadallah-Kallel A; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Tumour Biol; 2014 Aug; 35(8):7975-82. PubMed ID: 24833087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
    Huang Z; Li L; Wang J
    Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening.
    Amiot A; Mansour H; Baumgaertner I; Delchier JC; Tournigand C; Furet JP; Carrau JP; Canoui-Poitrine F; Sobhani I;
    PLoS One; 2014; 9(7):e99233. PubMed ID: 25025467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The variation trends of SFRP2 methylation of tissue, feces, and blood detection in colorectal cancer development.
    Sui C; Ma J; Chen Q; Yang Y
    Eur J Cancer Prev; 2016 Jul; 25(4):288-98. PubMed ID: 26258809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
    Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
    BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.